Toggle Main Menu Toggle Search

Open Access padlockePrints

Sarcopenia in patients undergoing lower limb bypass surgery is associated with higher mortality and major amputation rates

Lookup NU author(s): Dr Ashwin Sivaharan, Dr Luke Boylan, Professor Miles Witham, Dr Sandip Nandhra

Downloads

Full text for this publication is not currently held within this repository. Alternative links are provided below where available.


Abstract

© 2021Background: Sarcopenia is adversely associated with survival in several diseases. Vasculopathy is often associated with multimorbidity and consequent deconditioning with poor long-term outcomes. This study examined the impact of sarcopenia on clinical outcome in patients with and without critical limb-threatening ischaemia who underwent infrainguinal bypass surgery. Methods: All patients undergoing infra-inguinal surgical revascularisation in 2016–2018 were retrospectively reviewed. Sarcopenia was defined as a skeletal muscle area at the L3 vertebral level (defined as L3 muscle area < 114cm2 for men or <89.8cm2 for women) on CT angiography. The primary outcome was overall survival by analysed by time to event analysis. Secondary outcomes included ipsilateral major lower-limb amputation, length of hospital stay, myocardial infarction and surgical-site infection. Results: A total of 116 patients with a mean age of 66.9 years were included, with a mean follow-up of 21 months. 14 (12%) of patients were sarcopenic; there were more patients with diabetes (40% vs 7%) in the sarcopenic group, p=0.018. Age, gender, Rutherford grade at presentation, other co-morbidities, other laboratory tests, conduit material and Rutherford grade at presentation were similar in those with and without sarcopenia and were statistically insignificant upon testing. Overall survival was worse for sarcopenic patients (Log Rank P=0.001) and Hazard Ratio for death 5.8; 95%CI 1.8–19.1; P=0.001. Major lower-limb amputation occurred more frequently in patients with sarcopenia (7/14 [50%] vs 23/102 [23%]; P=0.046). There was no difference in other secondary outcomes including rates of graft occlusion, myocardial infarction, surgical site infection and length of stay. Adding SMA measurement to a multivariate generalised linear model including age, sex, diabetes, and haemoglobin improved the AUROC from 0.75–0.85. Conclusion: In this cohort of patients undergoing vascular surgery, sarcopenia defined using L3 muscle area was significantly associated with overall mortality and major lower-limb amputation.


Publication metadata

Author(s): Sivaharan A, Boylan L, Witham MD, Nandhra S

Publication type: Article

Publication status: Published

Journal: Annals of Vascular Surgery

Year: 2021

Pages: epub ahead of print

Online publication date: 02/04/2021

Acceptance date: 22/02/2021

ISSN (print): 0890-5096

ISSN (electronic): 1615-5947

Publisher: Elsevier Inc.

URL: https://doi.org/10.1016/j.avsg.2021.02.022

DOI: 10.1016/j.avsg.2021.02.022

PubMed id: 33819585


Altmetrics

Altmetrics provided by Altmetric


Actions

Find at Newcastle University icon    Link to this publication


Share